Members of Council - Declaration of Interest

Professor Bruce Robinson

  • Board Member MaynePharma and shareholder
  • Board Member Cochlear
  • Board Member Woolcock Institute
  • Advisory Board Member Astra Zeneca, Bayer and Eisai
  • Minter Ellison consultant
  • Qbiotics Board Member and shareholder
  • Firefly Board Member and Shareholder

Professor Anthony Lawler

  • Involved in development of and accreditation against training and clinical policy standards for emergency practice across Australia and New Zealand
  • Corporate and clinical governance responsibility for large COAG-initiated organisation providing strategic sourcing and contract management in telephony and digital health service offerings
  • Provide advice to the Directors of the AMC on the accreditation of specialist training providers (Specialist Colleges)
  • Responsible for acute purchasing strategies, clinical governance, medical workforce strategy, emergency preparedness and advice on complex ethical and clinical issues.

Professor Brendan Crabb

  • Since 2008 - Employed as Director and CEO, Burnet Institute, Melbourne
  • Since 2014- Director, Board of Research Australia Ltd
  • Since 2014- Chair, Victorian Chapter of Association of Australian Medical Research Institutes (AAMRI)
  • Since 2013- Chair, Alfred Medical Research & Education Precinct Council, Victoria
  • Since 2012- Member, Scientific Advisory Board (malaria), Wellcome Trust Sanger Institute, UK. Receive support for travel and accommodation to annual meeting
  • Since 2008- Member, PATH/MVI Vaccine Science Portfolio Advisory Council (VSPAC), USA (since 2008) Receive support for travel and accommodation to annual meeting
  • Since 2012 - Member, Scientific Advisory Board, Monash Institute of Pharmaceutical Sciences (MIPS)
  • Since 2012 - Chair, Papua New Guinea Institute of Medical Research International Buttressing Coalition
  • Since 2012- Director & Immediate Past President, Association of Australian Medical Research Institutes (AAMRI)
  • Since 2010 - Director, Board of AMREP Animal Services Pty Ltd, Victoria
  • Since 2001- Member, Board of the Gene Technology Access Centre (GTAC), Victoria
  • NHMRC grants currently held by me and my group

Professor Charles Guest

Shares in CSL Salary Victorian Department of Health and Human Services Fellow Australasian Faculty of Public Health Medicine

Professor Brendan Murphy

Board Member Centenary Institute of Cancer Medicine and Cell Biology

Professor David Story

Chair of Anaesthesia, The University of Melbourne  apart from institutional affiliations and current NHMRC funding

Professor Elizabeth Sullivan

  • Has received the following grants: NHMRC Project Grants (APP1109009, 2016-2018); (APP11088115, 2016-2020); (APP1078444, 2014-2018);(APP 1043693, 2013-2016); (APP1024206, 2012-2016);  (APP630653, 2010-2016); NHMRC Partnership Project (APP1028554, 2012-2016).   Has received funding from the Heart Foundation NSW CVRN Women and Heart Disease Grant. 2017-2019
  • Member, Obstetric Clinical Committee of the Medicare Benefits Schedule (MBS) Review Taskforce ; Member, Gynaecology Clinical Committee of the Medicare Benefits (MBS) Review Taskforce

Professor Gary Geelhoed

Member of:

  • AMA Federal Council
  • AMA Medical Workforce Committee
  • AHMAC Hospitals Principal Committee
  • Clinical Trials Advisory Committee
  • National Blood Authority’s Jurisdictional Blood Committee
  • Nationally Funded Centres Reference Group
  • Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Working Group
  • WA Health Translation Network Board

Professor Graeme Samuel

  • Leadership roles in a number of not for profit institutions that have an interest in the outcomes from health and medical research.
  • A director of and family holds a minority shareholding interest in two companies (Sonoeye Pty Ltd and Mupharma Pty Ltd) that are involved in medical research and may benefit from grants made by the NHMRC.

Dr Hugh Heggie

  • Board Member Health Providers Alliance NT

  • Member of Digital Health Agency Clinical and Technical Committe

  • Member of Radiation Health Advisory Council (Australian Radiation Protection and Nuclear Safety Agency)

Professor Ian Olver

  • Employed by University of South Australia
  • I hold 3 project grants and 1 partnership grant funded by NHMRC, 1 ARC linkage grant, 1 Sydney Catalyst Grant and one Cancer Australia grant. I am a CI on 3 further project grants and 2 Centre of Research Excellence Grants submitted in 2015
  • I have applied for 3 NHMRC Grants and 1 Translational Research Project.
  • I have consulted for the company Tesaro with UniSA receiving the funds.
  • I have engaged in educational activities with Teasro, Helsinn, Teva, Seqirus and Merck

Professor Ingrid Scheffer

  • Member of Editorial Board (Journals, no funding): Epileptic Disorders, Neurology, Epilepsy Currents, Progress in Epileptic Disorders Series
  • Has received funding for travel from: UCB, Athena Diagnostics, GlaxoSmithKline, Sanofi, Weizmann Institute, Ramaciotti Foundation, International League Against Epilepsy, Australian Academy of Science, Perpetual Charitable Trustees Has also received funding for travel from various universities, hospitals and associations
  • Has received honoraria/payment for lectures from: UCB, Eisai, Athena Diagnostics, Transgenomics, GlaxoSmithKline
  • Has received revenue for patent: Diagnostic and therapeutic methods for EFMR (WO/2009/08659)
  • Has received the following grants: HMRC Program Grant #628952 CI 2011-2015, 2016-2020 NHMRC Project Grant 2013-2015, 2016-2020 NIH Centre Without Walls funding "Epi4K" 2011-2015 The Tasmanian Infantile Epileptic Encephalopathy Project 2013-2015 Murdoch Childrens Research Institute Population Health Theme Funding 2015 March of Dimes Foundation 2015-17 Health Research Council of New Zealand 2015-18
  • Has received the following grants: NHMRC Practitioner Fellowship 2011-2015, 2016-2020
  • As part of my position within the International League Against Epilepsy I have created submissions relating to the classification of the epilepsies I am a member of the Victorian Law Reform Commission Medical Advisory Committee on Medicinal Cannabis
  • Has published translational work for families with individuals with epilepsy: Nation J, Cross H, Scheffer IE. Ketocooking: A practical guide to the ketogenic diet. The Homewood Press, UK 2012 Relevant publications: Berg AT, Berkovic SF, Brodie MJ, Buchhalter K, Cross JH, van Emde Boas W, Engel J, French K, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676-85. Epub 2010 Feb 26. Scheffer IE, Berg AT. Classification and clinical features of absence epilepsies: how evidence leads to changing concepts. Epilepsia 2008;49:2140-1 (invited commentary). Korff CM, Scheffer IE. Epilepsy classification – a cycle of evolution and revolution. Curr Opin Neurol 2013;26:163-7 (invited review). Scheffer IE. Epilepsy: a classification for all seasons? Epilepsia 2012;53(Suppl 2):6-9 (invited commentary). Berg AT, Scheffer IE. What is at stake in a classification? Epilepsia 2011;52:1205-8 (invited commentary). Berg A, Scheffer IE. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 2011;52:1058-62. (invited commentary)
  • Is a member of the following associations: International League Against Epilepsy - Chair, ILAE Classification Taskforce; ILAE Seizure Taskforce; ILAE Syndromes and Diagnostic Manual Taskforce Epilepsy Society of Australia International Child Neurology Association (member of research & nominating committee) Australian Epilepsy Clinical Trials Network Executive Committee L'Oreal For Women in Science Fellowships Committee Australian Academy of Science - Sectional Committee 12: Medicine and Public Health Australian Academy of Health and Medical Sciences Founding Vice-President and Fellow Twitter: @ingridscheffer Website:
  • Clinical Trials conducted with: UCB, Zogenix, Ultragenyx, INSYS
  • Member of Scientific Advisory Committee, The Clive and Vera Ramaciotti Foundation 2013-2015
  • GlaxoSmithKline Award for Research Excellence
  • Has given over 450 lectures (international and national) for various associations, universities and hospitals. Has given lectures for Eisai, GSK, Transgenomics, Sanofi, GlaxoSmithKline

Dr Jeannette Young

  • Member of QIMR Berghoffer Council
  • Chief Health Officer of Queensland
  • A family member has previously received NHMRC funding and may apply for funding in the future
  • Funding received as an investigator for a grant into Hendra research
  • Senior Executive In Queensland Department of Health with responsibility for the Office of Medical Research
  • Adjunct Professor at Queensland University of Technology
  • Adjunct Professor at Griffith University

Professor Jonathan Carapetis

  • Since 2012 - Employed as Director, Telethon Kids Institute, Subiaco, WA.  Not for Profit Child Health Research Institute
  • Since 2012 - Employed as Consultant Paediatrician, Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Subiaco, WA.
  • Since 2012 - Employed as Professor, Centre for Child Health Research, The University of Western Australia, Nedlands, WA.
  • Adjunct Professor, University of Queensland
  • Honorary Professor, University of Cape Town
  • Honorary Fellow with the Murdoch Children’s Research Institute
  • Honorary Distinguished Research Fellow of the Walter and Eliza Hall Institute of Medical Research
  • Since 2015 - Member, RHDAustralia Advisory Committee (ARC); Member, NHMRC Australia Council; Editorial Board Member, Heart Asia, British Medical Journal; Member, The University of Western Australia, Forrest Foundation Selection Committee; Member, WA Health Translation Network (WAHTN) Executive Board
  • Since 2014 - Member, Association of Australian Medical Research Institutes (AAMRI) Board; Member, Australian Academy of Health and Medical Sciences (AAHMS) Finance Committee; Member, Australian Indigenous Doctors’ Association (AIDA); Member, Department of Corrective Services WA, Youth Justice Board; Member, CSL Young Florey Medical Selection Committee; Chair, Australian Academy of Health and Medical Sciences (AAHMS) Selection Committee 12; Member, Australian Academy of Health and Medical Sciences (AAHMS) Council
  • Since 2013-  Member, Western Australian Immunisation Strategy Implementation Steering    Committee (WAISISC); Chair, Clinical Advisory Group, WA RHD Control Program
  • Since 2012- Member, Western Australian State Health Research Advisory Council (SHRAC); Executive Director, Telethon Kids Institute Board of Directors; Member, Australian Institute of Company Directors; Member, Program Management Committee, RHD Australia
  • Since 2011- Editorial Board Member, Global Heart Journal, World Heart Federation and Elsevier; Working Group on Rheumatic Fever and Rheumatic Heart Disease, World Heart Federation, Geneva
  • Since 2010- Board Member, One Disease at a Time Foundation
  • Since 2008- Expert Group Core Member and Head, Expert Group on Rheumatic Heart Disease, Cardiovascular Diseases Expert Group, Global Burden of Diseases, Injuries, and Risk Factors Study
  • Since 2007-  National Committee for Medicine, Australian Academy of Science.
  • Currently CI on three NHMRC CREs (CIA # 1080401; CIB on # 102170, CII on #1110341), three NHMRC Project Grants (CIA on # 1027040, CIF#1098319, CIC #1099183), a Co-principal investigator on an NHMRC & NZ Health Research Council grant and a CI on the NHMRC Targeted Call for Research (TCR) Grant (#1113531) in genomics medicine.
  • 2016-20: NHMRC Targeted Call for Research Grant 1113531. Preparing Australia for genomics medicine: A proposal by the Australian Genomics Health Alliance.  Chief Investigators:  K North,…, J Carapetis, et al.  $25,000,000.
  • 2016-20: NHMRC Research Grant 1110341. Centre of Research Excellence in reducing the effects of antenatal alcohol on child health (REAACH). Chief Investigators:  C Bower, E Elliott, J Fitzpatrick, R Watkins, H D’Antoine, J Oscar, R Giglia, S Zubrick, J Carapetis. $2,497,397.
  • 2016-20: NHMRC Project Grant 1098319. Optimising intervention strategies to reduce  the burden of Group A Streptococcus in Aboriginal Communities, S Tong, J McVernon, R Andrews, N Geard, R Dhurrkay, J Carapetis, B Currie, A Steer, P Giffard, A Bowen. $856,896.
  • 2016-20: NHMRC Project Grant 1099183. Group A streptococcal human challenge study: accelerating vaccine development, A Steer, M Batzloff, J Carapetis, P Smeesters, C Waddington, M Pandey, J Dale, T Schuster. $2,018,741.
  • 2016-17: AusTrade Commonwealth Grant Agreement ATMC50298. Towards a new long-acting penicillin formulation for rheumatic fever. J Carapetis. $223,134 | Novartis Institutes for BioMedical Research, Inc $175,234 | Wesfarmers Centre of Vaccines and Infectious Diseases $47,900.
  • 2015-19: NHMRC Research Grant 1080401. Centre of Research Excellence in developing an endgame for rheumatic heart disease in Australia.  Chief Investigators: J Carapetis, B Currie, G Maguire, D Bessarab, D McAullay, H D’Antoine, A Brown, K Edmond, A Street, N de Klerk.  $2,500,000.

Ms Karen Carey

  • Founder and major shareholder in Tonic Health Media Pty Ltd
  • Consumer Representative NBA Patient Blood Management Steering Committee
  • Personal Health Interest Organ Transplantation

Profressor Kathryn North

Nil apart from institutional affiliations and current NHMRC funding

Dr Kerry Chant

  • NSW Ministry of Health
  • I own shares in Wesfarmers & Telstra
  • Member of AFPHM

Professor Michael Kidd

  • Employed as executive dean of the Faculty of Medicine, Nursing and Health Sciences at Flinders University
  • Not for profit organisation for mental health, director fees paid
  • Not for profit medical publishing company, producing guidelines for medication management
  • Primary care service company owned by Flinders University and Charles Darwin University
  • Assisted reproductive technology company owned by Flinders University and SA Health
  • Flinders University nominee on board, not for profit charitable organisation supporting research, no director fees paid
  • Not for profit research foundation, no director fees paid
  • Employed as Professor of General Practice at University of Sydney, 1996-2009
  • Not for profit research institute for Aboriginal and Torres Strait Islander Health, Representative of Flinders University
  • Elected fellow of Australian Academy of Health and Medical Sciences
  • Australian Government funded organisation supporting medical students interested in a career in general practice
  • Australian Government funded organisation supporting doctors in training in the speciality of general practice
  • Not for profit global organisation, in collaborative relations with the World Health Organization, representing over 500,000 family doctors in over 140 countries. No director fees paid
  • Regular consultancy work with the World Health Organization. Honorarium, travel, accommodation paid
  • Medical journal published by BioMed Central/Springer, honorarium paid
  • Chief Investigator or Associate Investigator on current NHMRC grants
  • General practitioner, medical educator, primary care researcher and medical leader

Professor Paddy Phillips

  • Family member has sat on, and I think continues to sit on, pharmaceutical company advisory boards in the area of diabetes and endocrinology. I do not know which ones
  • I am employed by both Flinders University and SA Health.
  • Family member has a share portfolio but I do not know what is in it that relates to the biomedical and health sciences sector.

Dr Paul Kelly

  • ACT Health-employment
  • ANU - adjunct appointment.

Professor Sandra Eades

  • Since 2008 I have been employed by Baker IDI an independent medical research institute
  • I currently hold NHMRC project grants as an investigator
  • I have previously held a NHMRC people support grant and I am likely to hold a NHMRC people support grant in the future
  • Board Member on Outback Stores

Professor Sharon Lewin

  • Consultant to Tetralogic Pty Ltd, Calimmune Pty Ltd, Geovax Pty Ltd and Abivax Pty Ltd
  • I am a chief investigator on NHMRC project grants, program grant, practitioner fellowship and a partnership grant I recieve funds from the National Institutes for Health, Wellcome Trust, American Foundation for AIDS Research and University of Malaya for research projects. I have received funding to support investigator initiatied projects from Viiv Healthcare, Merck, Gilead Sciences and Tetralogic.
  • I have received honoraria paid to my institution for providing advice to Gilead Sciences and Bristol Myers Squibb
  • I have participated in advisory boards to Merck and Gilead. Payments are made to my institution
  • In the last 2 years, I have participated in educational activities organised by Viiv Healthcare, Merck and Gilead. All honoraria have been paid to my institution